Merck pauses Keytruda studies to assess patient deaths
admin 13th June 2017 Uncategorised 0Merck has paused new enrolment in two studies assessing its immunotherapy Keytruda treatment in combination with other therapies in multiple myeloma to address safety concerns.
More: Merck pauses Keytruda studies to assess patient deaths
Source: News